ArticleFrontiers in oncology2023

CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia.

Laurène Pousse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.